BORA PHARMACEUTICALS LTD (6472) — Financial Flexibility Index
BORA PHARMACEUTICALS LTD (6472) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of NT$1.38 Billion (operating CF NT$1.17 Billion minus capex NT$204.93 Million) represents 0% of total liabilities (NT$27.24 Billion). Also explore 6472 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BORA PHARMACEUTICALS LTD Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for BORA PHARMACEUTICALS LTD across 7 annual periods. Check 6472 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for BORA PHARMACEUTICALS LTD (2019–2025)
Year-by-year free cash flow to debt coverage for BORA PHARMACEUTICALS LTD. For the full company profile including market capitalisation, see 6472 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | NT$5.17 Billion | NT$4.24 Billion | NT$27.24 Billion | ▲ +248.1% |
| 2024 | 0.05x | NT$1.67 Billion | NT$980.81 Million | NT$30.59 Billion | ▼ -88.0% |
| 2023 | 0.45x | NT$6.04 Billion | NT$4.61 Billion | NT$13.29 Billion | ▲ +262.7% |
| 2022 | 0.13x | NT$2.21 Billion | NT$2.01 Billion | NT$17.62 Billion | ▼ -66.9% |
| 2021 | 0.38x | NT$1.60 Billion | NT$1.24 Billion | NT$4.22 Billion | ▲ +421.8% |
| 2020 | 0.07x | NT$329.88 Million | NT$177.79 Million | NT$4.54 Billion | ▼ -86.5% |
| 2019 | 0.54x | NT$929.10 Million | NT$231.77 Million | NT$1.73 Billion | — |